Art. 15 Directive (EU) 2001/83

In forcesince 26 Jan 2007cited 7×

An application for special, simplified registration may cover a series of medicinal products derived from the same homeopathic stock or stocks. The following documents shall be included with the application in order to demonstrate, in particular, the pharmaceutical quality and the batch-to-batch homogeneity of the products concerned:

scientific name or other name given in a pharmacopoeia of the homeopathic stock or stocks, together with a statement of the various routes of administration, pharmaceutical forms and degree of dilution to be registered,

dossier describing how the homeopathic stock or stocks is/are obtained and controlled, and justifying its/their homeopathic use, on the basis of an adequate bibliography,

manufacturing and control file for each pharmaceutical form and a description of the method of dilution and potentization,

manufacturing authorization for the medicinal product concerned,

copies of any registrations or authorizations obtained for the same medicinal product in other Member States,

one or more mock-ups of the outer packaging and the immediate packaging of the medicinal products to be registered,

data concerning the stability of the medicinal product.

  • Directive (EU) 2004/27Lawamends

  • Judgment of the Court (Second Chamber) of 12 May 2005. Meta Fackler KG v Bundesrepublik Deutschland.Decisioninterprets

    The questions referred for a preliminary ruling concern the interpretation of Articles 14 and 15 of Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products …

    12 May 2005 · 62003CJ0444

  • Judgment of the Court (Eighth Chamber) of 23 April 2020. Deutsche Homöopathie-Union (DHU) Arzneimittel GmbH & Co. KG v Bundesrepublik DeutscDecision

    However, it is apparent from Articles 13 to 16 of Directive 2001/83, which form part of Chapter 2 of that directive, entitled ‘Specific provisions applicable to homeopathic medicinal products’, in turn contained in Title III of that …

    23 Apr 2020 · 62019CJ0101

  • Opinion of Mr Advocate General Léger delivered on 27 January 2005. Meta Fackler KG v Bundesrepublik Deutschland.Decision

    At the same time, I think I should focus my assessment on the main question to emerge from the various queries raised by the national court, that is: should Articles 14 and 15 of Directive 2001/83 be interpreted as precluding a national …

    27 Jan 2005 · 62003CC0444

  • Raad van State, 03-06-2009, 200806401/1/H3Decision

    Ingevolge artikel 15 van Richtlijn 2001/83/EG, zoals dit luidde vóór inwerkingtreding van Richtlijn 2004/27/EG, gaat het verzoek om een speciale vereenvoudigde registratie vergezeld van, volgens de Nederlandstalige tekst: "een dossier …

    3 Jun 2009 · ECLI:NL:RVS:2009:BI6074

  • Raad van State, 07-11-2007, 200608238/1Decision

    Volgens de Engelstalige tekst van artikel 15 van Richtlijn 2001/83/EG gaat het verzoek om een speciale vereenvoudigde registratie vergezeld van een "dossier describing how the homeopathic stock or stocks is/are obtained and controlled, and …

    7 Nov 2007 · ECLI:NL:RVS:2007:BB7305

  • Regeling proeven op farmaceutische productenLaw

    … in artikel 1, lid 5, van richtlijn 2001/83. Module 3 Module 3 is van toepassing op de documenten die overeenkomstig artikel 15, van richtlijn 2001/83, worden ingediend bij de vereenvoudigde registratie van de in artikel 14, lid 1, van …